Author:
Ang Lawrence,Thani Khalid Bin,Ilapakurti Manjusha,Lee Michael S.,Palakodeti Vachaspathi,Mahmud Ehtisham
Subject
Cardiology and Cardiovascular Medicine
Reference35 articles.
1. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation;Yusuf;N Engl J Med,2001
2. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
3. Monitoring antiplatelet therapy during peripheral vascular and coronary interventions;Mahmud;Tech Vasc Interv Radiol,2006
4. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate;Bonello;J Am Coll Cardiol,2010
5. Stone GW. Patients with acute coronary syndrome and/or diabetes who show poor response to dual antiplatelet therapy as measured by platelet function testing are at greater risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents. Results of the ADAPT-DES (Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents) Registry. Paper presented at: the 23rd Annual Transcatheter Cardiovascular Therapeutics Scientific Symposium; November 9, 2011; San Francisco, CA.
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献